Moonwalk Biosciences
SOUTH SAN FRANCISCO, California · Biotechnology
Moonwalk Biosciences is an early-stage therapeutics company co-founded by Dr. Feng Zhang and leading experts in cell state epigenetics including Alex Aravanis, the former CTO of Illumina. The company has developed a differentiated approach to mapping the epigenome of cellular states at the whole genome, single cell resolution level, as well as proprietary strategies for precise epigenetic engineer
Key facts
- Headquarters
- SOUTH SAN FRANCISCO, California
- Employees
- 21
- Industries
- Biotechnology
- Status
- Private
- Website
- moonwalk.bio
- Company page
Recent activity at Moonwalk Biosciences
Moonwalk Biosciences funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2026 | Series B | $70.0M |
Leadership
- Alex, CEO
- Rigel, Head of Immunology Research
- John Liles, Vice President
Verified email and direct lines for Moonwalk Biosciences’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Moonwalk Biosciences in the news
- Moonwalk Biosciences Closes $70 Million Series B - Pharmaceutical Executive (Sep 08, 2026)
- Moonwalk Biosciences Raises $70 Million to Advance Adipose RNAi for Obesity - BioPharm International (Sep 08, 2026)
- Moonwalk Biosciences Announces $70 Million Series B Financing to Advance Adipose-Targeted RNAi Therapies for Obesity and Cardiometabolic Diseases - Business Wire (Sep 08, 2026)
- Moonwalk pulls in $70M to take fat-targeting RNAi obesity candidate to clinic - BioSpace (Sep 08, 2026)
- Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update - Yahoo! Finance Canada (Sep 09, 2026)
- Moonwalk Bio Grabs $57 Million, Joins Push for ‘Epigenetic’ Treatments - WSJ (Jan 05, 2024)
- Moonwalk Biosciences Launches with $57 Million in Financing to Advance a New Class of Precision Epigenetic Medicines - BioSpace (Jan 04, 2024)
- Moonwalk Biosciences to Present Data Showcasing EpiRead™ and EpiWrite™ Next-Generation Multiplex Epigenetic Engineering Platform at ASGCT 2024 - Business Wire (Apr 22, 2024)
Companies similar to Moonwalk Biosciences
- CytoDyn · Biotechnology
- Montara Therapeutics · Biotechnology
- Quantitative Biosciences Institute · Biotechnology
- PDS Biotech · Biotechnology
- Nami Surgical · Biotechnology
About Moonwalk Biosciences: questions and answers
What does Moonwalk Biosciences do?
Moonwalk Biosciences is an early-stage therapeutics company co-founded by Dr. Feng Zhang and leading experts in cell state epigenetics including Alex Aravanis, the former CTO of Illumina. The company has developed a differentiated approach to mapping the epigenome of cellular states at the whole genome, single cell resolution level, as well as proprietary strategies for precise epigenetic engineer
Where is Moonwalk Biosciences headquartered?
Moonwalk Biosciences is headquartered in SOUTH SAN FRANCISCO, California.
How many employees does Moonwalk Biosciences have?
Moonwalk Biosciences has about 21 employees.
Has Moonwalk Biosciences raised funding?
Yes. Fundz has recorded 1 funding event for Moonwalk Biosciences. The most recent, Series B of $70.0M, was in Sep 2026.
Who leads Moonwalk Biosciences?
Alex is a CEO at Moonwalk Biosciences.
What is the latest news on Moonwalk Biosciences?
On Sep 08, 2026, Moonwalk Biosciences secures $70 million in Series B financing to advance its adipose-targeted RNAi therapies for obesity and related diseases.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy